))
AI Clinical Trial Negotiators
Manage episode 481895253 series 3506216
Content provided by Darshan Kulkarni. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Darshan Kulkarni or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Today, we're diving into a hot topic in clinical trials: should you use AI to negotiate your next clinical trial agreement? Darshan is joined by Elizabeth from the University of Cincinnati and Istvan Fekete from Huron Consulting, who share their experiences and thoughts on using AI for contract and budget negotiations. They discuss the potential and limits of AI, highlighting concerns over copyright, data ownership, and "black box" decision-making. While AI can streamline contract review with tools like word plugins, there's consensus that human oversight will remain crucial. AI can help create initial drafts and flag key points, but will people over-rely on it, missing critical details in the process?
Istvan emphasizes that even with AI assistance, human expertise in contract review remains irreplaceable. Elizabeth raises a thought-provoking question: Will AI reduce the number of people at conferences like Magi in ten years, or will it expand the industry as AI tools increase contract efficiency? We’ll find out!
#AI #clinicaltrials #clinicalresearch #AIinclinicaltrials #pharmainnovation #smartnegotiations #legalinnovation #contractnegotiation #clinicaltrialtech #clinicaltrialagreements #pharmaregulations #clinicaltrialtech #darshantalks #dt #kulkarnilawfirm #klf #recentrecap
224 episodes
Share
